OverviewChartNewsTraderScreen

BNP Paribas Knock-Out SNW/  DE000PD5YXL5  /

Frankfurt Zert./BNP
5/16/2024  9:20:25 PM Chg.-0.060 Bid9:55:11 PM Ask9:55:11 PM Underlying Strike price Expiration date Option type
2.720EUR -2.16% 2.730
Bid Size: 3,600		 2.780
Ask Size: 3,600		 SANOFI SA INHABER ... 62.7708 - 12/31/2078 Call
GlobeNewswire 5/16 MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients wit...
GlobeNewswire 5/16 JD.com Announces First Quarter 2024 Results
GlobeNewswire 5/13 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire 5/13 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
TeleTrader 5/13 Europe mixed at open as CPI prints loom
GlobeNewswire 5/13 Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
TeleTrader 5/10 Novavax skyrockets 213.5% in premarket, highest in 16 months
TeleTrader 5/10 Novavax soars 39.6% in premarket after Sanofi license deal
GlobeNewswire 5/10 Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire 5/9 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
TeleTrader 5/9 Europe opens mixed with BoE in focus
GlobeNewswire 5/8 IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/7 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 5/2 Regeneron Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 5/2 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 4/30 Press Release: Annual General Meeting of April 30, 2024
TeleTrader 4/25 Europe opens mostly down after corporate earnings
TeleTrader 4/25 Europe down in premarket as financial results pour in
TeleTrader 4/25 Sanofi books net sales of €10.5B in Q1, up 2.4%
GlobeNewswire 4/25 Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire 4/23 Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire 4/17 IGM Biosciences Announces Refocusing of Sanofi Collaboration
GlobeNewswire 4/17 Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
GlobeNewswire 4/16 2024 DTA Summit Agenda is LIVE!!
GlobeNewswire 4/10 Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Upda...